CSN Login
Members Online: 16

RAS mutation may be even more important than determining treatment options, according to MDAnderson study

coloCan
Posts: 1873
Joined: Oct 2009

www.mdanderson.org/publications/oncolog/ras-mutation-status-may-predict-outcomes-after-surgery-for-colorectal-cancer-liver-metastases-oncol

Direct link doesn't seem to work,but if you type in "ras mutation" in search box of page that appears, you'll get this interesting article,if so interested (key word:"MAY")

(something calledCH4987655 (Ro4987655) is a MEK inhibitor that may prove useful with Ras/Raf mutations,tho in early phase trial 

Also,MGD007 is starting to enroll people for trial......and its not named for James Bonds' unknown cousin)

 

 

coloCan
Posts: 1873
Joined: Oct 2009

a company named Xbiotech is starting to enroll people in a phase III study of something called "Xilonix"....FYI

(again,FDA may be fast-tracking MGD007)

 

coloCan
Posts: 1873
Joined: Oct 2009

Sym004...................

and here's something someone may find of interest onKRAS/NRAS mutations(interesting site too)

www.mycancergenome.org/content/disease/colorectal-cancer/nras/316

PS:Just came across this,a combo of cetuximab and trastuzumab

http://onlinelibrary.wiley.com/doi/10.1111/cpr.12125/abstract

 

 

Quick2Listen
Posts: 1
Joined: Jun 2014

Although there are many genetic mutations classified as Kras + Tumors with mutated KRAS genes do not respond to treatment with cetuximab or panitumumab as yet

 

coloCan
Posts: 1873
Joined: Oct 2009

Supposedly good results thus far for Xilonix

www.sys-con.com/node/3168361

and phaae III starting for MGN 1703 (tho i think in Germany now)

also,good news from phase iii on Ramucirumab........

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network